Clinical Trial Update: VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for VPM1002BC in recurrent non-muscle invasive bladder cancer across Phase 1 and Phase 2, status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• VPM1002BC

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Bladder Cancer | Phase 1, Phase 2 | Status: COMPLETED